Taro Pharmaceutical Industries Ltd (TARO.N)
24 Feb 2017
MUMBAI, Feb 14 India's largest drugmaker Sun Pharmaceutical Industries Ltd's third-quarter profit fell below analysts' estimates due to slower sales in the United States, its largest market.
* Taro Pharmaceutical Industries Ltd qtrly net income per ordinary share from continuing operations attributable to taro $3.42 Source text for Eikon: Further company coverage:
* Taro Pharmaceutical Industries Ltd- Uday Baldota as chief executive officer
* Taro Pharmaceutical Industries Ltd - qtrly loss per share $0.00
* Appointment of Mariano Balaguer as vice president, CFO and chief accounting officer, effective today Source text for Eikon: Further company coverage:
WASHINGTON Taro Pharmaceutical Industries Ltd and two of its senior officers received grand jury subpoenas last week in connection with a federal antitrust investigation into generic drug pricing, the company disclosed.
WASHINGTON, Sept 11 Taro Pharmaceutical Industries Ltd and two of its senior officers received grand jury subpoenas last week in connection with a federal antitrust investigation into generic drug pricing, the company disclosed.
|Ranbaxy Laboratories Limited (RANB.NS)||Rs859.80||--|
|Pfizer Inc. (PFE.N)||$34.26||+0.20|
|Novartis AG (NOVN.S)||CHF77.60||0.00|
|Merck & Co., Inc. (MRK.N)||$66.16||+0.31|
|Bayer AG (BAYGn.DE)||€104.25||-0.85|
|Bayer AG (BAYE.F)||--||--|
|GlaxoSmithKline plc (GSK.L)||1,639.50||+7.00|
|Eli Lilly and Co (LLY.N)||$82.87||+0.32|
|Teva Pharmaceutical Industries Limited (TEVA.TA)||13,200.00||-260.00|
|Bristol-Myers Squibb Co (BMY.N)||$56.44||+0.67|